DE602004018916D1 - Verfahren zur synthese konformationell gehinderter peptide, peptidometika und deren verwendung als synthetische impfstoffe - Google Patents
Verfahren zur synthese konformationell gehinderter peptide, peptidometika und deren verwendung als synthetische impfstoffeInfo
- Publication number
- DE602004018916D1 DE602004018916D1 DE602004018916T DE602004018916T DE602004018916D1 DE 602004018916 D1 DE602004018916 D1 DE 602004018916D1 DE 602004018916 T DE602004018916 T DE 602004018916T DE 602004018916 T DE602004018916 T DE 602004018916T DE 602004018916 D1 DE602004018916 D1 DE 602004018916D1
- Authority
- DE
- Germany
- Prior art keywords
- peptides
- relates
- disappeaged
- peptidometics
- link
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 3
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- 229940126577 synthetic vaccine Drugs 0.000 title 1
- 230000002434 immunopotentiative effect Effects 0.000 abstract 2
- 239000000816 peptidomimetic Substances 0.000 abstract 2
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 239000000277 virosome Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
- C07K16/205—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Virology (AREA)
- General Physics & Mathematics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03012520A EP1484336A1 (de) | 2003-06-02 | 2003-06-02 | Methode zur Herstellung von konformationseingeschränkten Peptiden, Peptidomimetika und deren Verwendung als synthetische Vaccine |
| PCT/EP2004/005952 WO2004106366A1 (en) | 2003-06-02 | 2004-06-02 | Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004018916D1 true DE602004018916D1 (de) | 2009-02-26 |
Family
ID=33155135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004018916T Expired - Lifetime DE602004018916D1 (de) | 2003-06-02 | 2004-06-02 | Verfahren zur synthese konformationell gehinderter peptide, peptidometika und deren verwendung als synthetische impfstoffe |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7569541B2 (de) |
| EP (2) | EP1484336A1 (de) |
| AT (1) | ATE420100T1 (de) |
| AU (1) | AU2004242787B9 (de) |
| CA (1) | CA2527795C (de) |
| DE (1) | DE602004018916D1 (de) |
| DK (1) | DK1629002T3 (de) |
| ES (1) | ES2320660T3 (de) |
| WO (1) | WO2004106366A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| EP2014279A1 (de) | 2007-06-22 | 2009-01-14 | Pevion Biotech AG | Virosomen enthaltend Haemagglutinin, das von über Zelllinien hergestellten Influenza-Viren stammt, Zusammensetzungen, Herstellungsverfahren, Verwendung davon |
| US8771693B2 (en) * | 2009-10-27 | 2014-07-08 | Beth Israel Deaconess Medical Center, Inc. | Methods and compositions for the generation and use of conformation-specific antibodies |
| KR101831459B1 (ko) | 2010-03-03 | 2018-04-04 | 더 유니버시티 오브 브리티시 콜롬비아 | 올리고머 특이적 아밀로이드 베타 에피토프 및 항체 |
| WO2012149334A2 (en) * | 2011-04-27 | 2012-11-01 | Beth Israel Deaconess Medical Center, Inc. | Methods and compositions for the generation and use of conformation-specific antibodies |
| US9688747B2 (en) | 2013-03-15 | 2017-06-27 | Beth Israel Deaconess Medical Center, Inc. | Methods and compositions for the generation and use of conformation-specific antibodies |
| CN108350052A (zh) | 2015-11-09 | 2018-07-31 | 英属哥伦比亚大学 | 淀粉样蛋白β中间区域中的表位及其构象选择性抗体 |
| DE102016100898B4 (de) * | 2016-01-20 | 2021-08-12 | Infineon Technologies Ag | Chipkarte und Verfahren zum Ausbilden einer Chipkarte |
| WO2018232062A1 (en) * | 2017-06-15 | 2018-12-20 | University Of Washington | Macrocyclic polypeptides |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0341603A3 (de) * | 1988-05-09 | 1990-07-04 | Abbott Laboratories | Atriale Peptid-Derivate |
-
2003
- 2003-06-02 EP EP03012520A patent/EP1484336A1/de not_active Withdrawn
-
2004
- 2004-06-02 AU AU2004242787A patent/AU2004242787B9/en not_active Ceased
- 2004-06-02 WO PCT/EP2004/005952 patent/WO2004106366A1/en active Search and Examination
- 2004-06-02 AT AT04739532T patent/ATE420100T1/de active
- 2004-06-02 DK DK04739532T patent/DK1629002T3/da active
- 2004-06-02 US US10/559,010 patent/US7569541B2/en not_active Expired - Fee Related
- 2004-06-02 DE DE602004018916T patent/DE602004018916D1/de not_active Expired - Lifetime
- 2004-06-02 EP EP04739532A patent/EP1629002B1/de not_active Expired - Lifetime
- 2004-06-02 CA CA2527795A patent/CA2527795C/en not_active Expired - Fee Related
- 2004-06-02 ES ES04739532T patent/ES2320660T3/es not_active Expired - Lifetime
-
2009
- 2009-07-08 US US12/499,500 patent/US20110008414A9/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE420100T1 (de) | 2009-01-15 |
| AU2004242787B2 (en) | 2010-05-27 |
| EP1629002B1 (de) | 2009-01-07 |
| US20060258564A1 (en) | 2006-11-16 |
| EP1484336A1 (de) | 2004-12-08 |
| EP1629002A1 (de) | 2006-03-01 |
| CA2527795A1 (en) | 2004-12-09 |
| CA2527795C (en) | 2014-04-22 |
| AU2004242787B9 (en) | 2010-10-14 |
| WO2004106366A8 (en) | 2005-02-03 |
| AU2004242787B8 (en) | 2010-07-15 |
| DK1629002T3 (da) | 2009-04-14 |
| AU2004242787A1 (en) | 2004-12-09 |
| US20110008414A9 (en) | 2011-01-13 |
| ES2320660T3 (es) | 2009-05-27 |
| WO2004106366A1 (en) | 2004-12-09 |
| US20090324707A1 (en) | 2009-12-31 |
| US7569541B2 (en) | 2009-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006031811A3 (en) | Glycopegylated interferon alpha | |
| WO2006074467A3 (en) | Glycopegylated granulocyte colony stimulating factor | |
| RU2016120641A (ru) | Новые полипептиды | |
| DE602004018916D1 (de) | Verfahren zur synthese konformationell gehinderter peptide, peptidometika und deren verwendung als synthetische impfstoffe | |
| RU2009100884A (ru) | Пептидные фрагменты для индукции синтеза белков внеклеточного матрикса | |
| WO2005055946A3 (en) | Glycopegylated granulocyte colony stimulating factor | |
| US20050036980A1 (en) | Peptides for enhanced cell attachment and cell growth | |
| DE602004001727D1 (de) | Verfahren zur herstellung cyclischer peptide | |
| DE602005020165D1 (de) | Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin | |
| RU2008137796A (ru) | Пептиды и производные пептидов, а также содержащие их фармацевтические композиции | |
| WO2006014429A3 (en) | Cidofovir peptide conjugates as prodrugs | |
| MX2009012326A (es) | Peptidos de señalizacion. | |
| WO2006103101A3 (en) | MEANS FOR THE INHIBITION OF ANTI-β1-ADRENERGIC RECEPTOR ANTIBODIES | |
| MY147920A (en) | Antibacterial and antiviral peptides from actinomadura namibiensis | |
| RU2009102195A (ru) | Белок-связывающие производные метотрексата и содержащие их лекарства | |
| US11124542B2 (en) | Modulators of melanocortin receptors | |
| MX2011004176A (es) | Peptido-epitope rab6kifl/kif20a y vacunas que contienen el mismo. | |
| ATE451384T1 (de) | Verfahren zur herstellung von peptiden | |
| Limal et al. | Solid-phase synthesis of N, N′-unsymmetrically substituted ureas: application to the synthesis of carbaza peptides | |
| Lozano et al. | Development of designed site-directed pseudopeptide-peptido-mimetic immunogens as novel minimal subunit-vaccine candidates for malaria | |
| KR20090009839A (ko) | 면역조절 올리고펩티드 | |
| DE60310958D1 (de) | Synthese und charakterisierung neuer systeme zum hinführen und zur vektorisierung von molekülen von therapeutischem interesse zu targetzellen | |
| ES2589884T3 (es) | Derivados de ácido aspártico | |
| Stefanowicz et al. | Threonine at position 6 is not essential for the immunosuppressive activity of HLA-DQ (β164–172)-hexapeptide | |
| Ekkati et al. | Preparation of N-acetyl, tert-butyl amide derivatives of the 20 natural amino acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: MYMETICS CORP., NEW YORK, N.Y., US |
|
| 8364 | No opposition during term of opposition |